1.200
+9,09%
2026-09-11
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -214.2% | +10.8% | 2 / 3 | -20.5% | -10.56 pp | -1.87 pp | -4.1% | -5.46 | 10.96 | 93,1 | −20,5% | −1,0 | −214,2% | 10.96 | -1.69 | — |
| Pts | 0 | 0 | 8 | 0 | 0 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.200 (close price on 2026-09-11)EPS (TTM): 109,5
Financial charts
1.Revenue & growth
VND bn93,1Q2/26
1.Revenue & growth
VND bn93,1Q2/26
2.Profit & growth
VND bn-1,06Q2/26
3.Profit mix (Penman)
VND bn3,84Q2/26
4.Margins & cost structure
%15.6%Q2/26
5.Returns & cash cycle
% · days1.0%Q2/26
6.Earnings quality & cash
VND bn4,85Q2/26
7.Asset structure
VND bn837Q2/26
8.Funding & debt health
VND bn · times837Q2/26
9.Revenue backlog
VND bn0,73Q2/26
10.Valuation
times · %11,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-30Q2/26
Adjusted EPS growth, latest quarter
-218%
Average adjusted EPS growth, 3 quarters
-218%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26